Connect with us
Biocross, founded in 2005 as a spin-off of the Spanish National Research Council (CSIC), develops in-vitro diagnostic systems with multiple applications in prevention, clinical research, early...
As a result of the campaign's success, MJN-neuro has decided to extend the campaign for more than 50 days to raise more funds and to have...
The company has offices in Madrid, Barcelona and Mexico, the latter covering several Latin American countries. To date, iDoctus has invested $5.9 million (€5 million) in...
Clinicas Mi is a group of clinics of Catalan origin, owned by the Masfurroll family, a surname with a long tradition in Spanish healthcare. At the...
This summer, Exheus has received an Enisa loan amounting to $236,000 (€200,000). This is a long-term loan issued by the Ministry and offers extended repayment and...
ExeVir is a spin-off of VIB and is headed by German Dr. Torsten Mummenbrauer, a virologist who has worked for GSK Morphosys, Hookipa Pharma and Velvio....
Grifols has assured that 87.93% of bondholders of its secured bonds, 81.01% of unsecured bonds, the required 93.82% of underwriters of its syndicated credit facility, and...
Valneva will soon be able to sell its Covid-19 vaccine candidate. On the European side, Valneva has broken off negotiations with the European Commission, preferring bilateral...
Before being authorized, the vaccine developed by Hipra will have to pass stage I/II, where its safety will have to be demonstrated. Phase III will then...
Gilead's peak revenue in Spain was in 2015 when the company had a turnover $1.15 billion (€978.5 million). Those figures were due to the commercialization of...
 |
|
 |  |
 |
|